Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Integrative Proteomics Inc.

This article was originally published in Start Up

Executive Summary

Starting with linear amino acid sequence information, researchers are faced with the task of completing dossiers for particular proteins, filling in gaps in knowledge about their structures, their biochemical functions, and their physiological functions, to gain knowledge about what diseases or processes they regulate. Pharmaceutical and biotech companies know that this will ultimately result in drugs that interact with proteins to provide therapeutic benefits. The founders of Integrative Proteomics Inc. mean for this to happen sooner, rather than later. They have amassed a platform of protein-focused skills aimed at informing the drug discovery process at every step of the way, from target selection to lead optimization, and even at the marketing end, where proteomics could lead to population-customized drugs. The founders of IPI term their mission "pharmaceutical proteomics."

Related Content

The Proteomics Challenge


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts